First Trust Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.86M | Buy |
122,206
+22,009
| +22% | +$695K | ﹤0.01% | 1494 |
|
|
2025
Q1 | $3.33M | Sell |
100,197
-69,212
| -41% | -$2.3M | ﹤0.01% | 1534 |
|
|
2024
Q4 | $5.83M | Buy |
169,409
+121,810
| +256% | +$4.19M | 0.01% | 1277 |
|
|
2024
Q3 | $1.9M | Sell |
47,599
-21,823
| -31% | -$873K | ﹤0.01% | 1792 |
|
|
2024
Q2 | $2.09M | Buy |
69,422
+57,327
| +474% | +$1.73M | ﹤0.01% | 1690 |
|
|
2024
Q1 | $406K | Sell |
12,095
-23,152
| -66% | -$777K | ﹤0.01% | 2184 |
|
|
2023
Q4 | $1.14M | Buy |
35,247
+24,783
| +237% | +$800K | ﹤0.01% | 1945 |
|
|
2023
Q3 | $343K | Buy |
+10,464
| New | +$343K | ﹤0.01% | 2224 |
|
|
2023
Q2 | – | Sell |
-86,174
| Closed | -$2.81M | – | 2389 |
|
|
2023
Q1 | $2.81M | Sell |
86,174
-117,579
| -58% | -$3.84M | ﹤0.01% | 1535 |
|
|
2022
Q4 | $11.2M | Buy |
203,753
+12,934
| +7% | +$713K | 0.01% | 931 |
|
|
2022
Q3 | $8.45M | Buy |
190,819
+22,374
| +13% | +$991K | 0.01% | 999 |
|
|
2022
Q2 | $8.22M | Buy |
168,445
+6,045
| +4% | +$295K | 0.01% | 1020 |
|
|
2022
Q1 | $7.9M | Buy |
162,400
+47,775
| +42% | +$2.32M | 0.01% | 1120 |
|
|
2021
Q4 | $4.89M | Buy |
+114,625
| New | +$4.89M | ﹤0.01% | 1376 |
|
|
2020
Q4 | – | Sell |
-61,030
| Closed | -$2.07M | – | 2366 |
|
|
2020
Q3 | $2.07M | Buy |
+61,030
| New | +$2.07M | ﹤0.01% | 1353 |
|